Are tumor-associated carbohydrates the missing link between the gut microbiome and response to immune checkpoint inhibitor treatment in cancer?
Immune checkpoint inhibitor therapy has dramatically improved survival in a significant subset of patients with several solid tumor types. Increasing the number of patients benefitting from this form of therapy is an important translational research goal. Correlations between the composition of the...
Saved in:
| Main Authors: | Zoltan Szallasi, Aurel Prosz, Zsofia Sztupinszki, Judit Moldvay |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | OncoImmunology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/2162402X.2024.2324493 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Understanding the role of the gut microbiome in solid tumor responses to immune checkpoint inhibitors for personalized therapeutic strategies: a review
by: Mi Young Lim, et al.
Published: (2025-01-01) -
Natural killer cell antibody‐dependent cellular cytotoxicity to Plasmodium falciparum is impacted by cellular phenotypes, erythrocyte polymorphisms, parasite diversity and intensity of transmission
by: Stephen Tukwasibwe, et al.
Published: (2024-01-01) -
Developing an On‐Resin Synthesis of α‐Galactosylceramide‐Peptide Conjugate Vaccines
by: Dr. Michael A. Meijlink, et al.
Published: (2025-01-01) -
Complex Interaction between Gut Microbiome and Autoimmunity: Focus on Antiphospholipid Syndrome
by: Olalekan Chris Akinsulie, et al.
Published: (2024-10-01) -
Healthy gut microbiomes are host-controllable microbiomes
by: Théodore Bouchez, et al.
Published: (2025-01-01)